Interv Akut Kardiol. 2004;3(4):167-169
Interv Akut Kardiol. 2004;3(4):170-171
Interv Akut Kardiol. 2004;3(4):177-180
Introduction: Inferior vena cava filters offer a safe and effective way of pulmonary embolus prevention and reduction of complications when compared to earlier techniques of caval interruption. The aim of this presentation is to assess our experience with implantation of permanent caval filter TrapEase. Method: We performed retrospective analysis of 30 patients to whom 30 permanent caval filters were implantated in our ward, within the period of February 2000–January 2003. Indications for implantation permanent caval filter were: patients with contraindication to anticoagulative therapy and/or patients who have developed pulmonary embolism despite...
Interv Akut Kardiol. 2004;3(4):181-184
The authors present the analysis of the South Bohemian Coronary Registry which maps real-life treatment of ST-elevation myocardial infarction (STEMI) not only in the central cardiocenter but throughout the whole South Bohemian region. In 2003, total of 599 patients with diagnosed STEMI were admitted to the hospitals within the region. Out of this 464 patients were treated in the cardiocenter (CC): 162 patients directly from the cardiocenter referal area, 302 patients (65 %) were transferred from community hospitals to direct angioplasty (dPCI) from the distance 27–93 km. The overall in-hospital mortality in the STEMI patients was 7.5 %...
Interv Akut Kardiol. 2004;3(4):185-188
Cardiac resynchronization therapy is an accepted method for the treatment of chronic left ventricular failure in dilated cardiomyopathy associated with electromechanical dyssynchrony. Beneficial acute hemodynamic effects may be used in the treatment of acute heart failure following cardiac surgery. Available data from patients after surgical correction of congenital heart defects have shown multiple effects of resynchronization pacing in terms of increased arterial pressure, cardiac index and maximum ventricular +dP/dt. Temporary resynchronization pacing has been used as an alternative to mechanical circulatory support in patients who failed weaning...
Interv Akut Kardiol. 2004;3(4):189-191
Beta-blockers use is an essential part of modern treatment of acute myocardial infarction nowadays either in acute phase or in secondary prevention, which is supported by a great number of clinical studies. Contraindications are only hypertension, bradycardia, acute heart failure, bronchial asthma and advanced obstructive bronchopulmonary disease. Especially patients with extensive myocardial infarctions have the greatest benefit of such treatment. In spite of this positive effect, the administration of beta-blockers in patients with acute myocardial infarction is not fully utilized. The efforts is to initiate the treatment in as early phase of condition...
Interv Akut Kardiol. 2004;3(4):192-195
The survival and the quality of life in patients surviving cardiac arrest are markedly limited by postischemic encephalopathy that results from anoxia and reperfusion injury. The extent of brain damage can be diminished by therapeutic hypothermia that leads to the decrease of metabolism and suppression of pathogenetic mechanisms related to reperfusion injury. The decrease of body temperature to 32–34º for 12–24 hours can improve neurologic finding and mortality in patients after cardiac arrest. The most effective ways of decreasing body temperature are external cooling and infusion of iced fluids. Because of its efficacy, simplicity...
Interv Akut Kardiol. 2004;3(4):196-201
Mainstay in the treatment of acute coronary syndromes (ACS) both in a conservative and an interventional treatment arm is combined antithrombotic treatment. Thienopyridines (clopidogrel) and inhibitors of glycoprotein platelet receptors IIb/IIIa (IGPIIb/IIIa) abciximab, eptifibatid, tirofiban form a contribution to the modern antithrombotic pharmacotherapy. So the question is on the place when and whom to indicate this modern treatment and besides, due to the fact of high financial costs of IGPIIb/IIIa treatment and that it is not without a risk and has its contraindications. Large randomised studies demonstrated a benefit of IGPIIb/IIIa in the treatment...
Interv Akut Kardiol. 2004;3(4):202-204
64 years old male smoker with history of MI (anterior wall 10 years ago) was admitted to our hospital for direct PCI (chest pain lasting 5 hours, elevation of ST segment on EKG). On admission advanced heart failure indicated artificial ventilation. Direct PCI of circumflex branch (thrombotic occlusion) with implantation of 2 stents was performed. Two days later patient was transferred to the local hospital. Two days later it was necessary to perform new direct PCI due to incoming STEMI in the same location (thrombotic reocclusion) and the other reintervention we had to perform 5 days later. All together 4 stents have been implanted, during the second...
Interv Akut Kardiol. 2004;3(4):205-206
An acute myocardial infarction occurs quite rarely in pregnat women and is associated with high mortality for both, mother and fetus. A risk is the highest in the third trimester, in women younger than 35 years and in the case of delivery by Caesarian section. Authors describe a case of 32 years-old gypsy woman with risky behaviour and low compliance to the medical treatment. Patient was hospotalised 1st time at 32nd week of pregnancy for acute myocardial infarction of the inferior wall. On the 3rd day of hospitalisation she signed a negative letter of indemnity and left hospital. On the 2rd day after delivery reinfarction occured in the same region....
Interv Akut Kardiol. 2004;3(4):207-209
Haemodynamic significance of aortic stenosis along with symptomatology is often assessed according to left ventricle ejection fraction and aortic valve gradient. The authors present a case report of a patient with ejection fraction 60 % and relatively low mean aortic gradient were measured by ultrasound (37 mmHg) and catheterization (33 mmHg). Severe aortic stenosis with aortic valve area index 0,4 cm2/m2 was discovered by cardiac catheterization. Possible errors and pitfalls in aortic stenosis evaluation are presented. Catheterization technique developed at our department is discussed.
Interv Akut Kardiol. 2004;3(4)
Interv Akut Kardiol. 2004;3(4):211-212
Interv Akut Kardiol. 2004;3(4):213
Interv Akut Kardiol. 2004;3(4):214-218
Interv Akut Kardiol. 2004;3(4):219-220
Interv Akut Kardiol. 2004;3(4):221
Interv Akut Kardiol. 2004;3(4):222
Interv Akut Kardiol. 2004;3(4):210
Interv Akut Kardiol. 2004;3(4):224